FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Fabrizio Stocchi

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Procedures

Co-author Network

Publications

TOP 3
Kallol Ray Chaudhuri; Jose Manuel Rojo; Anthony H V Schapira; Fabrizio Stocchi; Angelo Antonini; David J Brooks; Richard J Brown; Per Odin; Pablo Martinez-Martin
A proposal for a comprehensive grading of Parkinson's disease severity combining motor and non-motor assessments: meeting an unmet need.
Fabrizio Stocchi; C Warren Olanow
Obstacles to the development of a neuroprotective therapy for Parkinson's disease.
C Warren Olanow; Jose A Obeso; Fabrizio Stocchi
The vatican meeting on neuroprotection for Parkinson's disease.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Fabrizio Stocchi (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Kallol Ray Chaudhuri; Jose Manuel Rojo; Anthony H V Schapira; Fabrizio Stocchi; Angelo Antonini; David J Brooks; Richard J Brown; Per Odin; Pablo Martinez-Martin
A proposal for a comprehensive grading of Parkinson's disease severity combining motor and non-motor assessments: meeting an unmet need.
PloS one 2013;8(2):e57221.
2013: Fabrizio Stocchi; C Warren Olanow
Obstacles to the development of a neuroprotective therapy for Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2013;28(1):3-7.
2013: C Warren Olanow; Jose A Obeso; Fabrizio Stocchi
The vatican meeting on neuroprotection for Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2013;28(1):1-2.
2011: Fabrizio Stocchi; Luigi Giorgi; Brian Hunter; Anthony H V Schapira
PREPARED: Comparison of prolonged and immediate release ropinirole in advanced Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2011;26(7):1259-65.
2010: Fabrizio Stocchi; Mario Zappia; Valentina Dall'Armi; Jaime Kulisevsky; Paolo Lamberti; José Angel Obeso
Melevodopa/carbidopa effervescent formulation in the treatment of motor fluctuations in advanced Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2010;25(12):1881-7.
2010: Fabrizio Stocchi; Olivier Rascol; Karl Kieburtz; Werner Poewe; Joseph Jankovic; Eduardo Tolosa; Paulo Barone; Anthony E Lang; C Warren Olanow
Initiating levodopa/carbidopa therapy with and without entacapone in early Parkinson disease: the STRIDE-PD study.
Annals of neurology 2010;68(1):18-27.
2010: Fabrizio Stocchi; Stefano Marconi
Factors associated with motor fluctuations and dyskinesia in Parkinson Disease: potential role of a new melevodopa plus carbidopa formulation (Sirio).
Clinical neuropharmacology 2010;33(4):198-203.
2010: Karla Eggert; David Squillacote; Paolo Barone; Richard Dodel; Regina Katzenschlager; Murat Emre; Andrew J Lees; Olivier Rascol; Werner Poewe; Eduardo Tolosa; Claudia Trenkwalder; Marco Onofrj; Fabrizio Stocchi; Giuseppe Nappi; Vladimir Kostic; Jagoda Potic; Evzen Ruzicka; Wolfgang Oertel
Safety and efficacy of perampanel in advanced Parkinson's disease: a randomized, placebo-controlled study.
Movement disorders : official journal of the Movement Disorder Society 2010;25(7):896-905.
2010: C Ciceroni; P Mosillo; E Mastrantoni; sale Patrizio; L Ricci-Vitiani; F Biagioni; Fabrizio Stocchi; F Nicoletti; D Melchiorri
mGLU3 metabotropic glutamate receptors modulate the differentiation of SVZ-derived neural stem cells towards the astrocytic lineage.
Glia 2010;58(7):813-22.
2010: K Ray Chaudhuri; Cristina Prieto-Jurcynska; Yogini Naidu; Tanya Mitra; Belen Frades-Payo; Susanne Tluk; Anne Ruessmann; Per Odin; Graeme Macphee; Fabrizio Stocchi; William G Ondo; Kapil D Sethi; Anthony H V Schapira; Juan Carlos Martinez Castrillo; Pablo Martinez-Martin
The nondeclaration of nonmotor symptoms of Parkinson's disease to health care professionals: an international study using the nonmotor symptoms questionnaire.
Movement disorders : official journal of the Movement Disorder Society 2010;25(6):704-9.
2010: Roberta Zangaglia; Fabrizio Stocchi; Massimo Sciarretta; Angelo Antonini; Francesca Mancini; Marco Guidi; Emilia Martignoni; Claudio Pacchetti
Clinical experiences with levodopa methylester (melevodopa) in patients with Parkinson disease experiencing motor fluctuations: an open-label observational study.
Clinical neuropharmacology 2010;33(2):61-6.
2010: Fabrizio Stocchi; Peter Jenner; Jose A Obeso
When do levodopa motor fluctuations first appear in Parkinson's disease?
European neurology 2010;63(5):257-66.
2010: Fabrizio Stocchi
The concept of continuous dopaminergic stimulation: what we should consider when starting Parkinson's disease treatment.
Neuro-degenerative diseases 2010;7(1-3):213-5.
2010: Carlo Colosimo; Letterio Morgante; Angelo Antonini; Paolo Barone; Tania P Avarello; Edo Bottacchi; Antonino Cannas; Maria Gabriella Ceravolo; Roberto Ceravolo; Giulio Cicarelli; Rosa M Gaglio; Luisa Giglia; Francesco Iemolo; Michela Manfredi; Giuseppe Meco; Alessandra Nicoletti; Massimo Pederzoli; Alfredo Petrone; Antonio Pisani; Francesco E Pontieri; Rocco Quatrale; Silvia Ramat; Rossana Scala; Giampiero Volpe; Salvatore Zappulla; Anna Rita Bentivoglio; Fabrizio Stocchi; Giorgio Trianni; Paolo Del Dotto; Lucia Simoni; Roberto Marconi
Non-motor symptoms in atypical and secondary parkinsonism: the PRIAMO study.
Journal of neurology 2010;257(1):5-14.
2009: Fabrizio Stocchi
Dopamine receptor agonists in the treatment of advanced Parkinson's disease.
Parkinsonism & related disorders 2009;15 Suppl 4():S54-7.
2009: Fabrizio Stocchi
The therapeutic concept of continuous dopaminergic stimulation (CDS) in the treatment of Parkinson's disease.
Parkinsonism & related disorders 2009;15 Suppl 3():S68-71.
2009: Marco Onofrj; Laura Bonanni; Giovanni Cossu; Davide Manca; Fabrizio Stocchi; Astrid Thomas
Emergencies in parkinsonism: akinetic crisis, life-threatening dyskinesias, and polyneuropathy during L-Dopa gel treatment.
Parkinsonism & related disorders 2009;15 Suppl 3():S233-6.
2009: Alessio Di Fonzo; Edito Fabrizio; Astrid Thomas; Emiliana Fincati; Roberto Marconi; Michele Tinazzi; Guido J Breedveld; Erik J Simons; Hsin F Chien; Joaquim J Ferreira; Martin W Horstink; Giovanni Abbruzzese; Barbara Borroni; Giovanni Cossu; Alessio Dalla Libera; Giovanni Fabbrini; Marco Guidi; Michele De Mari; Leonardo Lopiano; Emilia Martignoni; Paolo Marini; Marco Onofrj; Alessandro Padovani; Fabrizio Stocchi; Vincenzo Toni; Cristina Sampaio; Egberto R Barbosa; Giuseppe Meco; Ben A Oostra; Vincenzo Bonifati
GIGYF2 mutations are not a frequent cause of familial Parkinson's disease.
Parkinsonism & related disorders 2009;15(9):703-5.
2009: C Warren Olanow; Olivier Rascol; Robert Hauser; Paul D Feigin; Joseph Jankovic; Anthony Lang; William Langston; Eldad Melamed; Werner Poewe; Fabrizio Stocchi; Eduardo Tolosa
A double-blind, delayed-start trial of rasagiline in Parkinson's disease.
The New England journal of medicine 2009;361(13):1268-78.
2009: Paolo Barone; Angelo Antonini; Carlo Colosimo; Roberto Marconi; Letterio Morgante; Tania P Avarello; Eugenio Bottacchi; Antonino Cannas; Gabriella Ceravolo; Roberto Ceravolo; Giulio Cicarelli; Roberto M Gaglio; Rosa M Giglia; Francesco Iemolo; Michela Manfredi; Giuseppe Meco; Alessandra Nicoletti; Massimo Pederzoli; Alfredo Petrone; Antonio Pisani; Francesco E Pontieri; Rocco Quatrale; Silvia Ramat; Rosanna Scala; Giuseppe Volpe; Salvatore Zappulla; Anna Rita Bentivoglio; Fabrizio Stocchi; Giorgio Trianni; Paolo Del Dotto
The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2009;24(11):1641-9.
2009: Donald G Grosset; Angelo Antonini; Margherita Canesi; Gianni Pezzoli; Andrew J Lees; Karen Shaw; Esther Cubo; Pablo Martinez-Martin; Olivier Rascol; Laurence Negre-Pages; Ana Senard; Johannes Schwarz; Karl Strecker; Heinz Reichmann; Alexander Storch; Matthias Löhle; Fabrizio Stocchi; Katherine A Grosset
Adherence to antiparkinson medication in a multicenter European study.
Movement disorders : official journal of the Movement Disorder Society 2009;24(6):826-32.
2009: Nir Giladi; Joseph Tal; Tali Azulay; Olivier Rascol; David J Brooks; Eldad Melamed; Wolfgang H Oertel; Werner Poewe; Fabrizio Stocchi; Eduardo Tolosa
Validation of the freezing of gait questionnaire in patients with Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2009;24(5):655-61.
2009: Lucia Gatta; Alessio Cardinale; Francesca Wannenes; Claudia Consoli; Andrea Armani; Francesca Molinari; Caterina Mammi; Fabrizio Stocchi; Margherita Torti; Giuseppe M C Rosano; Massimo Fini
Peripheral blood mononuclear cells from mild cognitive impairment patients show deregulation of Bax and Sod1 mRNAs.
Neuroscience letters 2009;453(1):36-40.
2009: Fabrizio Stocchi
The hypothesis of the genesis of motor complications and continuous dopaminergic stimulation in the treatment of Parkinson's disease.
Parkinsonism & related disorders 2009;15 Suppl 1():S9-S15.
2008: Fabrizio Stocchi
Use of apomorphine in Parkinson's disease.
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2008;29 Suppl 5():S383-6.
2008: C Warren Olanow; Robert A Hauser; Joseph Jankovic; William Langston; Anthony E Lang; Werner Poewe; Eduardo Tolosa; Fabrizio Stocchi; Eldad Melamed; Eli Eyal; Olivier Rascol
A randomized, double-blind, placebo-controlled, delayed start study to assess rasagiline as a disease modifying therapy in Parkinson's disease (the ADAGIO study): rationale, design, and baseline characteristics.
Movement disorders : official journal of the Movement Disorder Society 2008;23(15):2194-201.
2008: Fabrizio Stocchi; Bonnie P Hersh; Burton L Scott; Paul A Nausieda; Luigi Giorgi
Ropinirole 24-hour prolonged release and ropinirole immediate release in early Parkinson's disease: a randomized, double-blind, non-inferiority crossover study.
Current medical research and opinion 2008;24(10):2883-95.
2008: Iran Sarichelou; Irene Cappuccio; F Ferranti; P Mosillo; C Ciceroni; sale Patrizio; Fabrizio Stocchi; Giuseppe Battaglia; Ferdinando Nicoletti; Daniela Melchiorri
Metabotropic glutamate receptors regulate differentiation of embryonic stem cells into GABAergic neurons.
Cell death and differentiation 2008;15(4):700-7.
2008: Fabrizio Stocchi; Michele Tagliati; C Warren Olanow
Treatment of levodopa-induced motor complications.
Movement disorders : official journal of the Movement Disorder Society 2008;23 Suppl 3():S599-612.
2007: K Ray Chaudhuri; Pablo Martinez-Martin; Richard Brown; Kapil D Sethi; Fabrizio Stocchi; Per Odin; William G Ondo; Kazuo Abe; Graeme Macphee; Doug MacMahon; Paolo Barone; Martin Rabey; Alison Forbes; Kieran Breen; Susanne Tluk; Yogini Naidu; Warren Olanow; Adrian J Williams; Sue Ann Thomas; David Rye; Yoshio Tsuboi; Annette Hand; Anthony H V Schapira
The metric properties of a novel non-motor symptoms scale for Parkinson's disease: Results from an international pilot study.
Movement disorders : official journal of the Movement Disorder Society 2007;22(13):1901-11.
2007: Pablo Martinez-Martin; Anthony H V Schapira; Fabrizio Stocchi; Kapil D Sethi; Per Odin; Graeme Macphee; Richard Brown; Yogini Naidu; Lisa Clayton; Kazuo Abe; Yoshio Tsuboi; Doug MacMahon; Paolo Barone; Martin Rabey; Ubaldo Bonuccelli; Alison Forbes; Kieran Breen; Susanne Tluk; C Warren Olanow; Sue Ann Thomas; David Rye; Annette Hand; Adrian J Williams; William G Ondo; K Ray Chaudhuri
Prevalence of nonmotor symptoms in Parkinson's disease in an international setting; study using nonmotor symptoms questionnaire in 545 patients.
Movement disorders : official journal of the Movement Disorder Society 2007;22(11):1623-9.
2007: Alessio Di Fonzo; Hsin F Chien; Mariana Peixoto Socal; Sabrina Giraudo; Cristina Tassorelli; G Iliceto; Giovanni Fabbrini; Roberto Marconi; E Fincati; Giovanni Abbruzzese; P Marini; Ferdinando Squitieri; Martin Horstink; Pasquale Montagna; A Dalla Libera; Fabrizio Stocchi; Stefano Goldwurm; Joaquim Ferreira; Giuseppe Meco; Emilia Martignoni; Leonardo Lopiano; Laura B Jardim; Ben A Oostra; Egberto R Barbosa; Vincenzo Bonifati
ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease.
Neurology 2007;68(19):1557-62.
2007: Rajesh Pahwa; Mark Stacy; Stewart A Factor; Kelly E Lyons; Fabrizio Stocchi; B P Hersh; L W Elmer; D D Truong; N L Earl
Ropinirole 24-hour prolonged release: randomized, controlled study in advanced Parkinson disease.
Neurology 2007;68(14):1108-15.
2007: Fabrizio Stocchi
Neuroprotection in Parkinson's disease: clinical trials.
Handbook of clinical neurology 2007;84():17-29.
2007: Fabrizio Stocchi; Laura Fabbri; Laszlo Vecsei; Anna Krygowska-Wajs; Piero Alessandro Monici Preti; Stefano A Ruggieri
Clinical efficacy of a single afternoon dose of effervescent levodopa-carbidopa preparation (CHF 1512) in fluctuating Parkinson disease.
Clinical neuropharmacology 2007;30(1):18-24.
2006: Astird Thomas; Laura Bonanni; Angelo Di Iorio; Sara Varanese; Francesca Anzellotti; Anna D'Andreagiovanni; Fabrizio Stocchi; Marco Onofrj
End-of-dose deterioration in non ergolinic dopamine agonist monotherapy of Parkinson's disease.
Journal of neurology 2006;253(12):1633-9.
2006: Mark Stacy; Robert A Hauser; Wolfgang H Oertel; Anthony H V Schapira; Kapil D Sethi; Fabrizio Stocchi; Eduardo Tolosa
End-of-dose wearing off in Parkinson disease: a 9-question survey assessment.
Clinical neuropharmacology 2006;29(6):312-21.
2006: Fabrizio Stocchi; Laura Vacca; P Grassini; Maria Francesca De Pandis; Giuseppe Battaglia; Carlo Cattaneo; Ruggero G Fariello
Symptom relief in Parkinson disease by safinamide: Biochemical and clinical evidence of efficacy beyond MAO-B inhibition.
Neurology 2006;67(7 Suppl 2):S24-9.
2006: C Warren Olanow; Jose A Obeso; Fabrizio Stocchi
Continuous dopamine-receptor treatment of Parkinson's disease: scientific rationale and clinical implications.
Lancet neurology 2006;5(8):677-87.
2006: C Warren Olanow; Jose A Obeso; Fabrizio Stocchi
Drug insight: Continuous dopaminergic stimulation in the treatment of Parkinson's disease.
Nature clinical practice. Neurology 2006;2(7):382-92.
2006: Giovanni Palleschi; ANTONIO PASTORE; Fabrizio Stocchi; Gino Bova; Maurizio Inghilleri; Sandra Sigala; Antonio Carbone
Correlation between the Overactive Bladder questionnaire (OAB-q) and urodynamic data of Parkinson disease patients affected by neurogenic detrusor overactivity during antimuscarinic treatment.
Clinical neuropharmacology 2006;29(4):220-9.
2006: Fabrizio Stocchi
The levodopa wearing-off phenomenon in Parkinson's disease: pharmacokinetic considerations.
Expert opinion on pharmacotherapy 2006;7(10):1399-407.
2006: K Ray Chaudhuri; Pablo Martinez-Martin; Anthony H V Schapira; Fabrizio Stocchi; Kapil D Sethi; Per Odin; Richard Brown; William Koller; Paolo Barone; Graeme Macphee; Linda Kelly; Martin Rabey; Doug MacMahon; Sue Ann Thomas; William G Ondo; David Rye; Alison Forbes; Susanne Tluk; Vijay Dhawan; Annette Bowron; Adrian J Williams; C Warren Olanow
International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson's disease: the NMSQuest study.
Movement disorders : official journal of the Movement Disorder Society 2006;21(7):916-23.
2006: Alessio Di Fonzo; Cristina Tassorelli; Michele De Mari; Hsin F Chien; Joaquim Ferreira; Christan F Rohé; Giulio Riboldazzi; Angelo Antonini; Gianni Albani; Alessandro Mauro; Roberto Marconi; Giovanni Abbruzzese; Leonardo Lopiano; Emiliana Fincati; Marco Guidi; Paolo Marini; Fabrizio Stocchi; Marco Onofrj; Vincenzo Toni; Michele Tinazzi; Giovanni Fabbrini; Paolo Lamberti; Nicola Vanacore; Giuseppe Meco; Petra Leitner; Ryan Uitti; Zbigniew K Wszolek; Thomas Gasser; Erik J Simons; Guido J Breedveld; Stefano Goldwurm; Gianni Pezzoli; Cristina Sampaio; Egberto Barbosa; Emilia Martignoni; Ben A Oostra; Vincenzo Bonifati
Comprehensive analysis of the LRRK2 gene in sixty families with Parkinson's disease.
European journal of human genetics : EJHG 2006;14(3):322-31.
2006: Fabrizio Stocchi
Rasagiline: defining the role of a novel therapy in the treatment of Parkinson's disease.
International journal of clinical practice 2006;60(2):215-21.
2006: Fabrizio Stocchi; Maria Francesca De Pandis
Utility of tolcapone in fluctuating Parkinson's disease.
Clinical interventions in aging 2006;1(4):317-25.
2005: Stefano Goldwurm; Alessio Di Fonzo; Erik J Simons; Christan F Rohé; Michela Zini; Margherita Canesi; Silvana Tesei; Anna Zecchinelli; Angelo Antonini; Claudio Mariani; Nicoletta Meucci; Giorgio Sacilotto; Francesca Sironi; Giuliana Salani; J Ferreira; H F Chien; Edito Fabrizio; N Vanacore; A Dalla Libera; Fabrizio Stocchi; Cosimo Diroma; P Lamberti; Cristina Sampaio; Giuseppe Meco; E Barbosa; Aida M Bertoli Avella; Guido J Breedveld; Ben A Oostra; Gianni Pezzoli; Vincenzo Bonifati
The G6055A (G2019S) mutation in LRRK2 is frequent in both early and late onset Parkinson's disease and originates from a common ancestor.
Journal of medical genetics 2005;42(11):e65.
2005: Fabrizio Stocchi
Optimising levodopa therapy for the management of Parkinson's disease.
Journal of neurology 2005;252 Suppl 4():IV43-IV48.
2005: Fabrizio Stocchi
Pathological gambling in Parkinson's disease.
Lancet neurology 2005;4(10):590-2.
2005: Vincenzo Bonifati; C F Rohé; G J Breedveld; E Fabrizio; M De Mari; C Tassorelli; A Tavella; R Marconi; D J Nicholl; H F Chien; E Fincati; G Abbruzzese; P Marini; A De Gaetano; Martin Horstink; anneke maat-kievit; Cristina Sampaio; Angelo Antonini; Fabrizio Stocchi; P Montagna; V Toni; M Guidi; A Dalla Libera; M Tinazzi; F De Pandis; G Fabbrini; S Goldwurm; A de Klein; E Barbosa; L Lopiano; E Martignoni; P Lamberti; N Vanacore; Giuseppe Meco; B A Oostra
Early-onset parkinsonism associated with PINK1 mutations: frequency, genotypes, and phenotypes.
Neurology 2005;65(1):87-95.
2005: Fabrizio Stocchi; Laura Vacca; Stefano Ruggieri; C Warren Olanow
Intermittent vs continuous levodopa administration in patients with advanced Parkinson disease: a clinical and pharmacokinetic study.
Archives of neurology 2005;62(6):905-10.
2005: Mark Stacy; Annette Bowron; Mark Guttman; Robert A Hauser; Kim Hughes; Jan Petter Larsen; Peter LeWitt; Wolfgang H Oertel; Niall Quinn; Kapil D Sethi; Fabrizio Stocchi
Identification of motor and nonmotor wearing-off in Parkinson's disease: comparison of a patient questionnaire versus a clinician assessment.
Movement disorders : official journal of the Movement Disorder Society 2005;20(6):726-33.
2005: Aida M Bertoli-Avella; José L Giroud-Benitez; Ali Akyol; Egberto Barbosa; Onno Schaap; Herma C van der Linde; Emilia Martignoni; Leonardo Lopiano; Paolo Lamberti; Emiliana Fincati; Angelo Antonini; Fabrizio Stocchi; Pasquale Montagna; Ferdinando Squitieri; Paolo Marini; Giovanni Abbruzzese; Giovanni Fabbrini; Roberto Marconi; Alessio Dalla Libera; Giorgio Trianni; Marco Guidi; Antonio De Gaetano; Gustavo Boff Maegawa; Antonino De Leo; Virgilio Gallai; Giulia de Rosa; Nicola Vanacore; Giuseppe Meco; C.M. Duijn; Ben A Oostra; Peter Heutink; Vincenzo Bonifati
Novel parkin mutations detected in patients with early-onset Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2005;20(4):424-31.
2005: Olivier Rascol; David J Brooks; Eldad Melamed; Wolfgang H Oertel; Werner Poewe; Fabrizio Stocchi; E Tolosa
Rasagiline as an adjunct to levodopa in patients with Parkinson's disease and motor fluctuations (LARGO, Lasting effect in Adjunct therapy with Rasagiline Given Once daily, study): a randomised, double-blind, parallel-group trial.
Lancet 2005;365(9463):947-54.
2005: Nicola Vanacore; Vincenzo Bonifati; Giovanni Fabbrini; Carlo Colosimo; Giuseppe De Michele; Roberto Marconi; Fabrizio Stocchi; David Nicholl; Ubaldo Bonuccelli; Michele De Mari; Peter Vieregge; Giuseppe Meco
Case-control study of multiple system atrophy.
Movement disorders : official journal of the Movement Disorder Society 2005;20(2):158-63.
2005: Alessio Di Fonzo; Christan F Rohé; Joaquim Ferreira; Hsin F Chien; Laura Vacca; Fabrizio Stocchi; Leonor Guedes; Edito Fabrizio; Mario Manfredi; Nicola Vanacore; Stefano Goldwurm; Guido J Breedveld; Cristina Sampaio; Giuseppe Meco; Egberto Barbosa; Ben A Oostra; Vincenzo Bonifati
A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease.
Lancet 2005;365(9457):412-5.
2004: C Warren Olanow; Yves Agid; Yoshikuni Mizuno; Alberto Albanese; Ubaldo Bonuccelli; U Bonucelli; Philippe Damier; Justo De Yebenes; Oscar S Gershanik; Mark Guttman; Francisco Grandas; Mark Hallett; Oleh Hornykiewicz; Peter Jenner; Regina Katzenschlager; William J Langston; Peter LeWitt; Eldad Melamed; M A Mena; Patrick P Michel; Catherine Mytilineou; Jose A Obeso; Werner Poewe; Niall Quinn; Rita Raisman-Vozari; Ali H Rajput; Olivier Rascol; Cristina Sampaio; Fabrizio Stocchi
Levodopa in the treatment of Parkinson's disease: current controversies.
Movement disorders : official journal of the Movement Disorder Society 2004;19(9):997-1005.
2004: Fabrizio Stocchi; G Arnold; Marco Onofrj; H Kwiecinski; A Szczudlik; A Thomas; Ubaldo Bonuccelli; A Van Dijk; Carlo Cattaneo; P Sala; Ruggero G Fariello
Improvement of motor function in early Parkinson disease by safinamide.
Neurology 2004;63(4):746-8.
2004: Alessandra Monge; Fabio Viselli; Fabrizio Stocchi; Luca Barbato; Andrea Bolner; Nicola Modugno; Michele Paradiso; Stefano Ruggieri; Gianpietro Nordera
Variation in the dopaminergic response during the day in Parkinson disease.
Clinical neuropharmacology 2004;27(3):116-8.
2004: Fabrizio Stocchi; Luca Barbato; Gianpietro Nordera; Andrea Bolner; T Caraceni
Entacapone improves the pharmacokinetic and therapeutic response of controlled release levodopa/carbidopa in Parkinson's patients.
Journal of neural transmission (Vienna, Austria : 1996) 2004;111(2):173-80.
2004: C Warren Olanow; Fabrizio Stocchi
COMT inhibitors in Parkinson's disease: can they prevent and/or reverse levodopa-induced motor complications?
Neurology 2004;62(1 Suppl 1):S72-81.
2004: Fabrizio Stocchi; C Warren Olanow
Continuous dopaminergic stimulation in early and advanced Parkinson's disease.
Neurology 2004;62(1 Suppl 1):S56-63.
2004: Letterio Morgante; Giorgio Basile; Antonio Epifanio; Edoardo Spina; Angelo Antonini; Fabrizio Stocchi; E Di Rosa; G Martino; Roberto Marconi; Paolino La Spina; Vittorio Nicita-Mauro; Antonio Enrico Di Rosa
Continuous apomorphine infusion (CAI) and neuropsychiatric disorders in patients with advanced Parkinson's disease: a follow-up of two years.
Archives of gerontology and geriatrics. Supplement 2004;(9):291-6.
2003: Fabrizio Stocchi; Laura Vacca; P Grassini; Giuseppe Battaglia; Marco Onofrj; M Valente; S Ruggieri
Optimizing levodopa pharmacokinetics in Parkinson's disease: the role of COMT inhibitor.
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2003;24(3):217-8.
2003: Antonio Enrico Di Rosa; Antonio Epifanio; Angelo Antonini; Fabrizio Stocchi; G Martino; L Di Blasi; A Tetto; Giorgio Basile; D Imbesi; Paolino La Spina; Giorgio Di Raimondo; Letterio Morgante
Continuous apomorphine infusion and neuropsychiatric disorders: a controlled study in patients with advanced Parkinson's disease.
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2003;24(3):174-5.
2003: Fabrizio Stocchi
Prevention and treatment of motor fluctuations.
Parkinsonism & related disorders 2003;9 Suppl 2():S73-81.
2003: Fabrizio Stocchi; Laura Vacca; Alfredo Berardelli; Marco Onofrj; Mario Manfredi; Stefano Ruggieri
Dual dopamine agonist treatment in Parkinson's disease.
Journal of neurology 2003;250(7):822-6.
2003: Fabrizio Stocchi; Alfredo Berardelli; Laura Vacca; Luca Barbato; Alessandra Monge; Gianpietro Nordera; Stefano Ruggieri
Apomorphine infusion and the long-duration response to levodopa in advanced Parkinson's disease.
Clinical neuropharmacology 2003;26(3):151-5.
2003: Fabrizio Stocchi; Gianpietro Nordera; Riitta H Jokinen; Ulla Lepola; Karen Hewett; Heather Bryson; Malini K Iyengar
Efficacy and tolerability of paroxetine for the long-term treatment of generalized anxiety disorder.
The Journal of clinical psychiatry 2003;64(3):250-8.
2003: Marco Onofrj; Anna Lisa Luciano; Diego Iacono; Astird Thomas; Fabrizio Stocchi; Franco Papola; Domenico Adorno; Rocco Di Mascio
HLA typing does not predict REM sleep behaviour disorder and hallucinations in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2003;18(3):337-40.
2003: Fabrizio Stocchi; C Warren Olanow
Neuroprotection in Parkinson's disease: clinical trials.
Annals of neurology 2003;53 Suppl 3():S87-97; discussion S97-9.
2003: Fabrizio Stocchi; Laura Vacca; Marco Onofrj
Are there clinically significant differences between dopamine agonists.
Advances in neurology 2003;91():259-66.
2002: Fabrizio Stocchi
Managing the critical problems of advanced Parkinson's disease.
Expert review of neurotherapeutics 2002;2(6):835-47.
2002: Fabrizio Stocchi; Alfredo Berardelli; Laura Vacca; A Thomas; Maria Francesca De Pandis; Nicola Modugno; M Valente; Stefano Ruggieri
Combination of two different dopamine agonists in the management of Parkinson's disease.
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2002;23 Suppl 2():S115-6.
2002: Maria Francesca De Pandis; A Starace; F Stefanelli; P Marruzzo; I Meoli; G De Simone; R Prati; Fabrizio Stocchi
Modification of respiratory function parameters in patients with severe Parkinson's disease.
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2002;23 Suppl 2():S69-70.
2002: Vincenzo Bonifati; Marieke C J Dekker; Nicola Vanacore; Giovanni Fabbrini; Ferdinando Squitieri; Roberto Marconi; Angelo Antonini; P Brustenghi; A Dalla Libera; Michele De Mari; Fabrizio Stocchi; P Montagna; V Gallai; Patrizia Rizzu; John C van Swieten; Ben A Oostra; C.M. Duijn; Giuseppe Meco; Peter Heutink
Autosomal recessive early onset parkinsonism is linked to three loci: PARK2, PARK6, and PARK7.
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2002;23 Suppl 2():S59-60.
2002: Fabrizio Stocchi; Stefano Ruggieri; Laura Vacca; C Warren Olanow
Prospective randomized trial of lisuride infusion versus oral levodopa in patients with Parkinson's disease.
Brain : a journal of neurology 2002;125(Pt 9):2058-66.
2002: ER Brunt; David J Brooks; Amos D Korczyn; Jean-Louis Montastruc; Fabrizio Stocchi
A six-month multicentre, double-blind, bromocriptine-controlled study of the safety and efficacy of ropinirole in the treatment of patients with Parkinson's disease not optimally controlled by L-dopa.
Journal of neural transmission (Vienna, Austria : 1996) 2002;109(4):489-502.
2001: Fabrizio Stocchi; Laura Vacca; Alfredo Berardelli; F De Pandis; Stefano Ruggieri
Long-duration effect and the postsynaptic compartment: study using a dopamine agonist with a short half-life.
Movement disorders : official journal of the Movement Disorder Society 2001;16(2):301-5.
2001: Nicola Vanacore; Vincenzo Bonifati; Giovanni Fabbrini; Carlo Colosimo; Giuseppe De Michele; Roberto Marconi; David Nicholl; Nicoletta Locuratolo; G Talarico; Silvia Romano; Fabrizio Stocchi; Ubaldo Bonuccelli; Michele De Mari; Peter Vieregge; Giuseppe Meco
Epidemiology of multiple system atrophy. ESGAP Consortium. European Study Group on Atypical Parkinsonisms.
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2001;22(1):97-9.
2001: Fabrizio Stocchi; Laura Vacca; Maria Francesca De Pandis; Luca Barbato; M Valente; Stefano Ruggieri
Subcutaneous continuous apomorphine infusion in fluctuating patients with Parkinson's disease: long-term results.
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2001;22(1):93-4.
2001: Nicola Vanacore; Vincenzo Bonifati; Carlo Colosimo; Giovanni Fabbrini; Giuseppe De Michele; Roberto Marconi; David Nicholl; Nicoletta Locuratolo; Silvia Romano; G Talarico; Fabrizio Stocchi; Ubaldo Bonuccelli; P Lamberti; Peter Vieregge; Giuseppe Meco
Epidemiology of progressive supranuclear palsy. ESGAP Consortium. European Study Group on Atypical Parkinsonisms.
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2001;22(1):101-3.
2001: Fabrizio Stocchi; Laura Vacca; M Valente; Stefano Ruggieri
Sleep disorders in Parkinson's disease.
Advances in neurology 2001;86():289-93.
2000: Milena De Marinis; Fabrizio Stocchi; Bruno Gregori; Neri Accornero
Sympathetic skin response and cardiovascular autonomic function tests in Parkinson's disease and multiple system atrophy with autonomic failure.
Movement disorders : official journal of the Movement Disorder Society 2000;15(6):1215-20.
2000: John G Nutt; Jose A Obeso; Fabrizio Stocchi
Continuous dopamine-receptor stimulation in advanced Parkinson's disease.
Trends in neurosciences 2000;23(10 Suppl):S109-15.
2000: C Warren Olanow; Fabrizio Stocchi
Why delaying levodopa is a good treatment strategy in early Parkinson's disease.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2000;7 Suppl 1():3-8.
2000: Fabrizio Stocchi; L Brusa
Cognition and emotion in different stages and subtypes of Parkinson's disease.
Journal of neurology 2000;247 Suppl 2():II114-21.
2000: Nicola Vanacore; Vincenzo Bonifati; Giovanni Fabbrini; Carlo Colosimo; Roberto Marconi; David Nicholl; Ubaldo Bonuccelli; Fabrizio Stocchi; P Lamberti; Giampiero Volpe; Giuseppe De Michele; IVANO IAVARONE; P Bennett; Peter Vieregge; Giuseppe Meco
Smoking habits in multiple system atrophy and progressive supranuclear palsy. European Study Group on Atypical Parkinsonisms.
Neurology 2000;54(1):114-9.
2000: Fabrizio Stocchi; Danilo Badiali; Laura Vacca; L D'Alba; F Bracci; Stefano Ruggieri; M Torti; Alfredo Berardelli; Enrico Corazziari
Anorectal function in multiple system atrophy and Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2000;15(1):71-6.
1999: David Nicholl; P Bennett; L Hiller; Vincenzo Bonifati; Nicola Vanacore; Giovanni Fabbrini; Roberto Marconi; Carlo Colosimo; P Lamberti; Fabrizio Stocchi; Ubaldo Bonuccelli; Peter Vieregge; D B Ramsden; Giuseppe Meco; AC Williams
A study of five candidate genes in Parkinson's disease and related neurodegenerative disorders. European Study Group on Atypical Parkinsonism.
Neurology 1999;53(7):1415-21.
1999: Vincenzo Bonifati; Marijke Joosse; David Nicholl; Nicola Vanacore; P Bennett; Patrizia Rizzu; Giovanni Fabbrini; Roberto Marconi; Carlo Colosimo; Nicoletta Locuratolo; Fabrizio Stocchi; Ubaldo Bonuccelli; Michele De Mari; G Wenning; Peter Vieregge; Ben A Oostra; Giuseppe Meco; Peter Heutink
The tau gene in progressive supranuclear palsy: exclusion of mutations in coding exons and exon 10 splice sites, and identification of a new intronic variant of the disease-associated H1 haplotype in Italian cases.
Neuroscience letters 1999;274(1):61-5.
1999: Piero Barbanti; Giovanni Fabbrini; Alberto Ricci; Rosanna Cerbo; Elena Bronzetti; Brunella Caronti; Caterina Calderaro; Laura Felici; Fabrizio Stocchi; Giuseppe Meco; Francesco Amenta; Gian Luigi Lenzi
Increased expression of dopamine receptors on lymphocytes in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 1999;14(5):764-71.
1999: Fabrizio Stocchi; C Farina; Gianpietro Nordera; Stefano Ruggieri
Implantable venous access system for apomorphine infusion in complicated Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 1999;14(2):358.
1999: A Taylor; A Beerahee; DR Citerone; M Davy; KL Fitzpatrick; A Lopez-Gil; Fabrizio Stocchi
The effect of steady-state ropinirole on plasma concentrations of digoxin in patients with Parkinson's disease.
British journal of clinical pharmacology 1999;47(2):219-22.
1999: Fabrizio Stocchi; Enrico Corazziari; A Carbone; Laura Vacca; Maria Francesca De Pandis; Alfredo Berardelli; Stefano Ruggieri
Urinary and anorectal function evaluation in Parkinson's disease.
Advances in neurology 1999;80():347-51.
1998: Fabrizio Stocchi; Alain Destée
Co-administration of ropinirole and domperidone during rapid dose escalation of the dopamine agonist.
Parkinsonism & related disorders 1998;4(4):183-8.
1998: P Bennett; Vincenzo Bonifati; Ubaldo Bonuccelli; Carlo Colosimo; Michele De Mari; Giovanni Fabbrini; Roberto Marconi; Giuseppe Meco; David Nicholl; Fabrizio Stocchi; Nicola Vanacore; Peter Vieregge; AC Williams
Direct genetic evidence for involvement of tau in progressive supranuclear palsy. European Study Group on Atypical Parkinsonism Consortium.
Neurology 1998;51(4):982-5.
1998: Fabrizio Stocchi; Luca Barbato; Gianpietro Nordera; Alfredo Berardelli; Stefano Ruggieri
Sleep disorders in Parkinson's disease.
Journal of neurology 1998;245 Suppl 1():S15-8.
1998: Anette Schrag; David J Brooks; E Brunt; D Fuell; Amos D Korczyn; Werner Poewe; Niall Quinn; Olivier Rascol; Fabrizio Stocchi
The safety of ropinirole, a selective nonergoline dopamine agonist, in patients with Parkinson's disease.
Clinical neuropharmacology 1998;21(3):169-75.
1998: Amos D Korczyn; David J Brooks; ER Brunt; Werner Poewe; Olivier Rascol; Fabrizio Stocchi
Ropinirole versus bromocriptine in the treatment of early Parkinson's disease: a 6-month interim report of a 3-year study. 053 Study Group.
Movement disorders : official journal of the Movement Disorder Society 1998;13(1):46-51.
1998: Olivier Rascol; David J Brooks; ER Brunt; Amos D Korczyn; Werner Poewe; Fabrizio Stocchi
Ropinirole in the treatment of early Parkinson's disease: a 6-month interim report of a 5-year levodopa-controlled study. 056 Study Group.
Movement disorders : official journal of the Movement Disorder Society 1998;13(1):39-45.
1997: Luca Barbato; Fabrizio Stocchi; Alessandra Monge; Laura Vacca; Stefano Ruggieri; Gianpietro Nordera; CD Marsden
The long-duration action of levodopa may be due to a postsynaptic effect.
Clinical neuropharmacology 1997;20(5):394-401.
1997: Andrea Bolner; Luca Barbato; F Tagliaro; Alessandra Monge; Fabrizio Stocchi; Gianpietro Nordera
Determination of apomorphine in human plasma by alumina extraction and high-performance liquid chromatography with electrochemical detection.
Forensic science international 1997;89(1-2):81-91.
1997: Stefano Ruggieri; Maria Francesca De Pandis; A Bonamartini; Laura Vacca; Fabrizio Stocchi
Low dose of clozapine in the treatment of dopaminergic psychosis in Parkinson's disease.
Clinical neuropharmacology 1997;20(3):204-9.
1997: Fabrizio Stocchi; A Carbone; Maurizio Inghilleri; A Monge; S Ruggieri; Alfredo Berardelli; Mario Manfredi
Urodynamic and neurophysiological evaluation in Parkinson's disease and multiple system atrophy.
Journal of neurology, neurosurgery, and psychiatry 1997;62(5):507-11.
1997: Fabrizio Stocchi; Gianpietro Nordera; CD Marsden
Strategies for treating patients with advanced Parkinson's disease with disastrous fluctuations and dyskinesias.
Clinical neuropharmacology 1997;20(2):95-115.
1996: Guido Palladini; S Ruggeri; Fabrizio Stocchi; Maria Francesca De Pandis; Giorgio Venturini; Vito Margotta
A pharmacological study of cocaine activity in planaria.
Comparative biochemistry and physiology. Part C, Pharmacology, toxicology & endocrinology 1996;115(1):41-5.
1996: Fabrizio Stocchi; Maria Francesca De Pandis; F A Delfino; T Anselmo; D Frongillo
Transient atrial fibrillation after subcutaneous apomorphine bolus.
Movement disorders : official journal of the Movement Disorder Society 1996;11(5):584-5.
1996: Luca Barbato; Alessandra Monge; Fabrizio Stocchi; Gianpietro Nordera
Melperone in the treatment of iatrogenic psychosis in Parkinson's disease.
Functional neurology 1996;11(4):201-7.
1996: Fabrizio Stocchi; Luca Barbato; L Bramante; Gianpietro Nordera; Laura Vacca; Stefano Ruggieri
Fluctuating parkinsonism: a pilot study of single afternoon dose of levodopa methyl ester.
Journal of neurology 1996;243(5):377-80.
1996: D Frongillo; Fabrizio Stocchi; F A Delfino; L Calò; L Bramante; F Antonucci; D De Nardo; S Ruggleri; D Cannata
QT interval and QT dispersion in multiple system atrophy (Shy-Drager syndrome).
Clinical autonomic research : official journal of the Clinical Autonomic Research Society 1996;6(2):67-70.
1996: Fabrizio Stocchi; A Bonamartini; Laura Vacca; Stefano Ruggieri
Motor fluctuations in levodopa treatment: clinical pharmacology.
European neurology 1996;36 Suppl 1():38-42.
1996: Stefano Ruggieri; Giovanni Fabbrini; L Bramante; F DePandis; Fabrizio Stocchi; Piero Barbanti; Laura Vacca; Mario Manfredi
An open study with reversible MAO-A inhibitors in complicated Parkinson's disease.
Advances in neurology 1996;69():595-8.
1996: Fabrizio Stocchi; A Carbone; M Inghilleri; D Frongillo; Luca Barbato; L Bramante; D Cannata; Mario Manfredi; Stefano Ruggieri
Instrumental diagnosis of multiple system atrophy.
Advances in neurology 1996;69():421-4.
1995: Mario Manfredi; Fabrizio Stocchi; Laura Vacca
Differential diagnosis of parkinsonism.
Journal of neural transmission. Supplementum 1995;45():1-9.
1995: M Vidailhet; P R Atchison; Fabrizio Stocchi; P D Thompson; John C Rothwell; CD Marsden
The bereitschaftspotential preceding stepping in patients with isolated gait ignition failure.
Movement disorders : official journal of the Movement Disorder Society 1995;10(1):18-21.
1995: D Frongillo; Fabrizio Stocchi; P Buccolini; P Stecconi; F Viselli; Stefano Ruggieri; D Cannata
Ambulatory blood pressure monitoring and cardiovascular function tests in multiple system atrophy.
Fundamental & clinical pharmacology 1995;9(2):187-96.
1994: Fabrizio Stocchi; Luca Barbato; L Bramante; A Bonamartini; Stefano Ruggieri
The clinical efficacy of a single afternoon dose of levodopa methyl ester: a double-blind cross-over study versus placebo.
Functional neurology 1994;9(5):259-64.
1994: Rocco Agostino; Alfredo Berardelli; A Formica; Fabrizio Stocchi; Neri Accornero; Mario Manfredi
Analysis of repetitive and nonrepetitive sequential arm movements in patients with Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 1994;9(3):311-4.
1994: Fabrizio Stocchi; Niall Quinn; Luca Barbato; P N Patsalos; M T O'Connel; Stefano Ruggieri; CD Marsden
Comparison between a fast and a slow release preparation of levodopa and a combination of the two: a clinical and pharmacokinetic study.
Clinical neuropharmacology 1994;17(1):38-44.
1994: Fabrizio Stocchi; P N Patsalos; Alfredo Berardelli; Luca Barbato; A Bonamartini; Mario Manfredi; Stefano Ruggieri
Clinical implications of sustained dopaminergic stimulation.
Clinical neuropharmacology 1994;17 Suppl 2():S7-13.
1993: M Vidailhet; Fabrizio Stocchi; John C Rothwell; P D Thompson; Brian L Day; David J Brooks; CD Marsden
The Bereitschaftspotential preceding simple foot movement and initiation of gait in Parkinson's disease.
Neurology 1993;43(9):1784-8.
1993: A Capria; A Attanasio; D Frongillo; Stefano Ruggieri; Fabrizio Stocchi
Transient left bundle branch block following intravenous lisuride bolus.
Fundamental & clinical pharmacology 1993;7(2):115-7.
1993: Fabrizio Stocchi; L Bramante; A Monge; F Viselli; fabio baronti; E Stefano; Stefano Ruggieri
Apomorphine and lisuride infusion. A comparative chronic study.
Advances in neurology 1993;60():653-5.
1993: Fabrizio Stocchi; Luca Barbato; A Carbone; Giovanni Fabbrini; Stefano Ruggieri; A Bonamartini; G Baffigo; A Agnoli
Urodynamic study in the differential diagnosis between multiple system atrophy and Parkinson's disease.
Advances in neurology 1993;60():434-7.
1992: M J Steiger; Fabrizio Stocchi; L Bramante; Stefano Ruggieri; Niall Quinn
The clinical efficacy of single morning doses of levodopa methyl ester: dispersible Madopar and Sinemet plus in Parkinson disease.
Clinical neuropharmacology 1992;15(6):501-4.
1992: Fabrizio Stocchi; Stefano Ruggieri; A Carta; J Ryatt; Niall Quinn; Peter Jenner; CD Marsden; A Agnoli
Intravenous boluses and continuous infusions of L-dopa methyl ester in fluctuating patients with Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 1992;7(3):249-56.
1992: L Lestingi; Vincenzo Bonifati; Fabrizio Stocchi; Italo Antonozzi; Giuseppe Meco
TRH test and the continuous dopaminergic stimulation in complicated Parkinson's disease.
European neurology 1992;32(2):65-9.
1991: Stefano Ruggieri; Fabrizio Stocchi; fabio baronti; F Viselli; R Horowski; C Lucarelli; A Agnoli
Antagonist effect of terguride in Parkinson's disease.
Clinical neuropharmacology 1991;14(5):450-6.
1991: Milena De Marinis; Fabrizio Stocchi; S R Testa; F De Pandis; A Agnoli
Alterations of thermoregulation in Parkinson's disease.
Functional neurology 1991;6(3):279-83.
1991: M J Steiger; Fabrizio Stocchi; A Carta; Stefano Ruggieri; A Agnoli; Niall Quinn; CD Marsden
The clinical efficacy of oral levodopa methyl ester solution in reversing afternoon "off" periods in Parkinson's disease.
Clinical neuropharmacology 1991;14(3):241-4.
1990: Alfredo Berardelli; A Carta; Fabrizio Stocchi; A Formica; A Agnoli; Mario Manfredi
Botulinum A toxin injection in patients with blepharospasm, torticollis and hemifacial spasm.
Italian journal of neurological sciences 1990;11(6):589-93.
1990: A Attanasio; A Capria; G Leggiadro; M Michisanti; D Cannata; Fabrizio Stocchi; Stefano Ruggieri
Transient cardiac arrest during continuous intravenous infusion of apomorphine.
Lancet 1990;336(8726):1321.
1990: C Lucarelli; P Betto; G Ricciarello; M Giambenedetti; C Corradini; Fabrizio Stocchi; F Belliardo
Simultaneous measurement of L-dopa, its metabolites and carbidopa in plasma of parkinsonian patients by improved sample pretreatment and high-performance liquid chromatographic determination.
Journal of chromatography 1990;511():167-76.
1989: Giorgio Venturini; Fabrizio Stocchi; Vito Margotta; Stefano Ruggieri; D Bravi; P Bellantuono; Guido Palladini
A pharmacological study of dopaminergic receptors in planaria.
Neuropharmacology 1989;28(12):1377-82.
1989: Fabrizio Stocchi; A Carta; Alfredo Berardelli; Angelo Antonini; M Argenta; A Formica; A Agnoli
Effects of terguride in patients with Huntington's disease.
Clinical neuropharmacology 1989;12(5):435-9.
1989: A Capria; A Attanasio; M Quatrana; D Cannata; Mario Fioravanti; Fabrizio Stocchi; Stefano Ruggieri
Cardiovascular effects of lisuride continuous intravenous infusion in fluctuating Parkinson's disease.
Clinical neuropharmacology 1989;12(4):331-8.
1989: S Ruggieri; Fabrizio Stocchi; A Carta; M Catarci; A Agnoli
Jejunal delivery of levodopa methyl ester.
Lancet 1989;2(8653):45-6.
1989: S Ruggieri; Fabrizio Stocchi; A Carta; A Agnoli
Side-effects of subcutaneous apomorphine in Parkinson's disease.
Lancet 1989;1(8637):566.
1989: Stefano Ruggieri; Fabrizio Stocchi; A Carta; M Bragoni; C Agostini; Luca Barbato; A Agnoli
One year treatment with lisuride delivery pump in Parkinson's disease.
Progress in neuro-psychopharmacology & biological psychiatry 1989;13(1-2):173-83.
1988: P Betto; G Ricciarello; M Giambenedetti; C Lucarelli; S Ruggeri; Fabrizio Stocchi
Improved high-performance liquid chromatographic analysis with double detection system for L-dopa, its metabolites and carbidopa in plasma of parkinsonian patients under L-dopa therapy.
Journal of chromatography 1988;459():341-9.
1988: Stefano Ruggieri; A Carta; Fabrizio Stocchi; Angelo Antonini; P Bellantuono; A Monge
Pharmacological strategies for controlling motor fluctuations in Parkinson's disease.
Functional neurology 1988;3(4):471-9.
1988: A Agnoli; Fabrizio Stocchi; A Carta; Angelo Antonini; M Bragoni; Stefano Ruggieri
Continuous dopaminergic stimulation in the management of complicated Parkinson's disease.
The Mount Sinai journal of medicine, New York 1988;55(1):62-6.
1988: Stefano Ruggieri; Fabrizio Stocchi; A Carta; D Bravi; M Bragoni; L Giorgi; A Agnoli
Comparison between L-dopa and lisuride intravenous infusions: a clinical study.
Movement disorders : official journal of the Movement Disorder Society 1988;3(4):313-9.
1988: Werner Krause; B Nieuweboer; S Ruggieri; Fabrizio Stocchi; I Suchy
Pharmacokinetics of lisuride after subcutaneous infusion.
Journal of neural transmission. Supplementum 1988;27():71-4.
1988: Fabrizio Stocchi; Stefano Ruggieri; Angelo Antonini; fabio baronti; G Brughitta; P Bellantuono; D Bravi; A Agnoli
Subcutaneous lisuride infusion in Parkinson's disease: clinical results using different modes of administration.
Journal of neural transmission. Supplementum 1988;27():27-33.
1988: Rocco Agostino; Alfredo Berardelli; Giorgio Cruccu; G Pauletti; Fabrizio Stocchi; Mario Manfredi
Correlation between facial involuntary movements and abnormalities of blink and corneal reflexes in Huntington's chorea.
Movement disorders : official journal of the Movement Disorder Society 1988;3(4):281-9.
1987: Fabrizio Stocchi; Stefano Ruggieri; fabio baronti; P Bellantuono; G Brughita; Angelo Antonini; D Bravi; A Agnoli
[On-off phenomena in Parkinson's disease. Continuous dopaminergic stimulation].
La Clinica terapeutica 1987;122(2):83-8.
1987: A Capria; Fabrizio Stocchi; A Attanasio; M Quatrana; D Cannata; Stefano Ruggieri
Unusual cardiovascular response to intravenous lisuride bolus. Possible drug-induced coronary angiospasm.
Chest 1987;91(5):792-3.
1987: Alfredo Berardelli; Fabrizio Stocchi; M Gallucci; Stefano Ruggieri; Neri Accornero; A Agnoli; Mario Manfredi
Neurophysiological and magnetic resonance studies in a patient with hemiballismus.
Functional neurology 1987;2(1):93-8.
1987: M H Marion; Fabrizio Stocchi; Niall Quinn; Peter Jenner; CD Marsden
Single-dose study of slow release preparation of levodopa and benserazide (Madopar HBS) in Parkinson's disease.
Advances in neurology 1987;45():493-6.
1987: Rocco Agostino; Alfredo Berardelli; Giorgio Cruccu; Fabrizio Stocchi; Mario Manfredi
Corneal and blink reflexes in Parkinson's disease with "on-off" fluctuations.
Movement disorders : official journal of the Movement Disorder Society 1987;2(4):227-35.
1987: M H Marion; Fabrizio Stocchi; S L Malcolm; Niall Quinn; Peter Jenner; CD Marsden
Single-dose studies of a slow-release preparation of levodopa and benserazide (Madopar HBS) in Parkinson's disease.
European neurology 1987;27 Suppl 1():54-8.
1986: Stefano Ruggieri; alessandro denaro; Giuseppe Meco; A Carta; Fabrizio Stocchi; A Agnoli
Multicenter trial of L-Deprenyl in Parkinson disease.
Italian journal of neurological sciences 1986;7(1):133-7.
1986: M H Marion; Fabrizio Stocchi; Niall Quinn; Peter Jenner; CD Marsden
Repeated levodopa infusions in fluctuating Parkinson's disease: clinical and pharmacokinetic data.
Clinical neuropharmacology 1986;9(2):165-81.
1986: Fabrizio Stocchi; Stefano Ruggieri; G Brughitta; A Agnoli
Problems in daily motor performances in Parkinson's disease: the continuous dopaminergic stimulation.
Journal of neural transmission. Supplementum 1986;22():209-18.
1986: Stefano Ruggieri; Fabrizio Stocchi; alessandro denaro; fabio baronti; A Agnoli
The role of MAO-b inhibitors in the treatment of Parkinson's disease.
Journal of neural transmission. Supplementum 1986;22():227-33.
1984: A Agnoli; S Ruggieri; alessandro denaro; N Martucci; G Tanfani; Fabrizio Stocchi
White matter disease (Binswanger's encephalopathy) in chronic cerebrovascular disorders.
Monographs in neural sciences 1984;11():144-9.
1984: A Agnoli; Stefano Ruggieri; Giuseppe Meco; M Casacchia; alessandro denaro; L Conti; L Bedini; Fabrizio Stocchi; Mario Fioravanti; A Franzese
An appraisal of the problem of dementia in Parkinson's disease.
Advances in neurology 1984;40():299-306.